Bioverativ Inc logo

BIVV - Bioverativ Inc News Story

$104.98 0.3  0.0%

Last Trade - 08/03/18

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £841.6m
Position in Universe th / 6846

BRIEF-Bioverativ Q4 Revenue Rose 28.3 Percent To $328.7 Million

Tue 13th February, 2018 9:15pm
Feb 13 (Reuters) - Bioverativ Inc  BIVV.O : 
    * BIOVERATIV REPORTS FOURTH QUARTER AND FULL YEAR 2017 
PERFORMANCE 
    * Q4 REVENUE ROSE 28.3 PERCENT TO $328.7 MILLION 
    * QTRLY SHR $1.30 
 
Source text for Eikon:  ID:nBwS3BxZa  
Further company coverage:  BIVV.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.